The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study
about
Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study MethodologiesImpact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South AfricaThe effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa’s Eastern Cape ProvinceTuberculosis innovations mean little if they cannot save livesSignificant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis.Economic challenges associated with tuberculosis diagnostic development.The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates.Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, PeruHigh prevelance of rifampin-monoresistant tuberculosis: a retrospective analysis among Iranian pulmonary tuberculosis patients.Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugsEconomic evaluations of point of care testing strategies for active tuberculosis.Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil.Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic ValueDiagnosis of opportunistic infections: HIV co-infections - tuberculosis.Compounding diagnostic delays: a qualitative study of point-of-care testing in South Africa.Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.
P2860
Q26767271-676CE34A-839E-46ED-8273-A52BBDC2DE77Q28394564-72DAF193-6772-42CF-B119-4E6A958EA643Q29247880-B45E4615-A856-48C7-B5D7-993C4BA72617Q33627409-E078C03A-3B81-4A16-A043-EC12B2A1418DQ35171825-DC9D6388-332B-4C98-B449-C3A2E256D64DQ36160928-29A05510-01F1-462F-9D3B-CBECAD7B45BBQ36564933-57ADB80C-FEAD-4E66-82F9-D0026FF74379Q36892449-C23A57B7-F96B-4FC6-A60C-CAE36F6FCD73Q37456208-2F14DA8D-6994-4689-8D0F-BB0BC362F99EQ37544293-46068A88-5FE7-4267-A165-CFFED95E4E3BQ38114142-594C8EE7-A696-42A3-BE6E-6073718FD1AFQ38623426-32863AC8-079E-4059-99BF-22DD317FAD12Q38999525-62CA2E56-915D-482D-8A12-4AC031FB134EQ39070206-6ECB4C57-A723-4FF6-8EFD-CB12A76BBCC5Q40242841-757458C2-44CE-40C0-9BCF-7FF887431AA6Q42687193-3BFD4222-B3B4-4963-AC18-8ED619FB33B4
P2860
The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The impact of expanded testing ...... an observational cohort study
@ast
The impact of expanded testing ...... an observational cohort study
@en
The impact of expanded testing ...... an observational cohort study
@nl
type
label
The impact of expanded testing ...... an observational cohort study
@ast
The impact of expanded testing ...... an observational cohort study
@en
The impact of expanded testing ...... an observational cohort study
@nl
prefLabel
The impact of expanded testing ...... an observational cohort study
@ast
The impact of expanded testing ...... an observational cohort study
@en
The impact of expanded testing ...... an observational cohort study
@nl
P2093
P2860
P921
P1433
P1476
The impact of expanded testing ...... an observational cohort study
@en
P2093
Gerrit Coetzee
Hendrik Koornhof
Jonathan E Golub
Linda Erasmus
Susan E Dorman
P2860
P304
P356
10.1371/JOURNAL.PONE.0049898
P407
P577
2012-01-01T00:00:00Z